Publications by authors named "Matthieu Conroy"

Claim this Profile
A
An observational time-series study on the behavioral effects of adjunctive artisanal cannabidiol use by adults with treatment resistant epilepsies.
Barbara A Brett, Matthieu Conroy, Hardik Doshi, Matthew X Lowe, Sasha Kalcheff-Korn

BMC Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic clearance of select opioids and opioid antagonists using hepatic spheroids and recombinant cytochrome P450 enzymes.
Wing Y Tuet, Samuel A Pierce, Matthieu Conroy, Justin N Vignola, Justin Tressler

Pharmacol Res Perspect· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyes.
Patrick M McNutt, Kyle E M Kelly, Amber C Altvater, Marian R Nelson, Megan E Lyman, Matthieu T Conroy

Toxicol Lett· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
Jacqueline M Tremblay, Edwin Vazquez-Cintron, Kwok-Ho Lam, Jean Mukherjee, Daniela Bedenice, Matthieu T Conroy

Toxins (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol.
Zackary Montoya, Matthieu Conroy, Brian D Vanden Heuvel, Christopher S Pauli, Sang-Hyuck Park

Front Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects.
Christopher S Pauli, Matthieu Conroy, Brian D Vanden Heuvel, Sang-Hyuck Park

Front Pharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis